The DOI matches its Crossref record; 261 of the 261 references it cites were found in a registry or an index.
Multiple system atrophy
Abstract
Multiple system atrophy (MSA) is a sporadic, adult-onset, relentlessly progressive neurodegenerative disorder, clinically characterized by various combinations of autonomic failure, parkinsonism and ataxia. The neuropathological hallmark of MSA are glial cytoplasmic inclusions consisting of misfolded α-synuclein. Selective atrophy and neuronal loss in striatonigral and olivopontocerebellar systems underlie the division into two main motor phenotypes of MSA-parkinsonian type and MSA-cerebellar type. Isolated autonomic failure and REM sleep behavior disorder are common premotor features of MSA. Beyond the core clinical symptoms, MSA manifests with a number of non-motor and motor features. Red flags highly specific for MSA may provide clues for a correct diagnosis, but in general the diagnostic accuracy of the second consensus criteria is suboptimal, particularly in early disease stages. In this chapter, the authors discuss the historical milestones, etiopathogenesis, neuropathological findings, clinical features, red flags, differential diagnosis, diagnostic criteria, imaging and other biomarkers, current treatment, unmet needs and future treatments for MSA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–261 of 261
Occupational therapy in multiple system atrophy: A pilot randomized controlled trial
Jain, S., Dawson, J., Quinn, N. P., & Playford, E. D. (2004) · Movement Disorders · doi:10.1002/mds.20211 · Cited by 56
Shao, N., Yang, J., & Shang, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.007 · Cited by 56
Clinical and Magnetic Resonance Imaging Characteristics of Sporadic Cerebellar Ataxia
Bürk, K., Bühring, U., Schulz, J. B., Zühlke, C., Hellenbroich, Y., & DICHGANS, J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.981 · Cited by 56
The phenotype spectrum of Japanese multiple system atrophy
Ozawa, T., Tada, M., Kakita, A., Onodera, O., Tada, M., Ishihara, T., Morita, T., Shimohata, T., Wakabayashi, K., Takahashi, H., et al. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.182576 · Cited by 54
Hyposmia in pure autonomic failure
Silveira‐Moriyama, L., Mathias, C. J., Mason, L., Best, C., Quinn, N. P., & Lees, A. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a55fd2 · Cited by 54
Imaging of dopaminergic dysfunction with [ 123 I]FP-CIT SPECT in early-onset parkin disease
Varrone, A., Pellecchia, M. T., Amboni, M., Sansone, V., Salvatore, E., Ghezzi, D., Garavaglia, B., Brice, A., Brunetti, A., Bonavita, V., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145765.19094.94 · Cited by 53
Haga, R., Sugimoto, K., Nishijima, H., Miki, Y., Suzuki, C., Wakabayashi, K., Baba, M., Yagihashi, S., & Tomiyama, M. (2015) · Parkinson s Disease · doi:10.1155/2015/167038 · Cited by 52
Discriminating among degenerative parkinsonisms using advanced 123I-ioflupane SPECT analyses
Badoud, S., Ville, D. V. D., Nicastro, N., Garibotto, V., Burkhard, P. R., & Haller, S. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.07.004 · Cited by 51
Olfactory bulb in multiple system atrophy
Kovács, T., Papp, M. I., Cairns, N. J., Khan, M. N., & Lantos, P. L. (2003) · Movement Disorders · doi:10.1002/mds.10466 · Cited by 50
Meissner, W. G., Laurencin, C., Tranchant, C., Witjas, T., Viallet, F., Guehl, D., Damier, P., Houéto, J., Tison, F., Eusébio, A., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.01.005 · Cited by 50
The natural history of idiopathic autonomic failure: The IAF-BO cohort study
Giannini, G., Buonaura, G. C., Asioli, G. M., Cecere, A., Barletta, G., Mignani, F., Ratti, S., Guaraldi, P., Provini, F., & Cortelli, P. (2018) · Neurology · doi:10.1212/wnl.0000000000006243 · Cited by 50
Krismer, F., Seppi, K., Göbel, G., Steiger, R., Zucal, I., Boesch, S., Gizewski, E. R., Wenning, G. K., Poewe, W. H., & Scherfler, C. (2019) · Movement Disorders · doi:10.1002/mds.27669 · Cited by 50
Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta‐analysis
Yu, F. F., Barron, D. S., Tantiwongkosi, B., & Fox, P. M. (2015) · Brain and Behavior · doi:10.1002/brb3.329 · Cited by 49
Laere, K. V., Clerinx, K., D’Hondt, E., de Groot, T., & Vandenberghe, W. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.070144 · Cited by 49
Viral‐mediated oligodendroglial alpha‐synuclein expression models multiple system atrophy
Bassil, F., Guerin, P. A., Dutheil, N., Li, Q., Klugmann, M., Meissner, W. G., Bézard, E., & Fernagut, P. (2017) · Movement Disorders · doi:10.1002/mds.27041 · Cited by 49
Bordet, R., Benhadjali, J., Destée, A., Belabbas, A., & Libersa, C. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199502000-00012 · Cited by 48
Should genetic testing for SCAs be included in the diagnostic workup for MSA?
Kim, H., Jeon, B. S., Shin, J. H., Lee, W., Park, H.-Y., Jung, Y. J., & Ehm, G. (2014) · Neurology · doi:10.1212/wnl.0000000000000965 · Cited by 48
Management of multiple system atrophy: state of the art
Colosimo, C., Tiple, D., & Wenning, G. K. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0379-0 · Cited by 45
Therapeutic strategies in multiple system atrophy
Wenning, G. K., Geser, F., & Poewe, W. H. (2005) · Movement Disorders · doi:10.1002/mds.20543 · Cited by 45
Sasaki, H., Emi, M., Iijima, H., Ito, N., Sato, H., Yabe, I., Kato, T., Utsumi, J., & Matsubara, K. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-24 · Cited by 44
Amantadine effectiveness in multiple system atrophy and progressive supranuclear palsy
Rajrut, A. H., Uitti, R. J., Fenton, M. E., & George, D. (1997) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(97)00022-9 · Cited by 43
PSP as Distinguished from CBD, MSA-P and PD by Clinical and Imaging Differences at an Early Stage
Kurata, T., Kametaka, S., Ohta, Y., Morimoto, N., Deguchi, S., Deguchi, K., Ikeda, Y., Takao, Y., Ohta, T., Manabe, Y., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5954 · Cited by 42
Definite familial multiple system atrophy with unknown genetics
Itoh, K., Kasai, T., Tsuji, Y., Saito, K., Mizuta, I., Harada, Y., Sudoh, S., Mizuno, T., Nakagawa, M., & Fushiki, S. (2014) · Neuropathology · doi:10.1111/neup.12092 · Cited by 41
Structural Imaging in Atypical Parkinsonism
Heim, B., Krismer, F., & Seppi, K. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.08.010 · Cited by 41
Gwinn, K. A., Devine, M. J., Jin, L., Johnson, J. O., Bird, T. D., Muenter, M. D., Waters, C., Adler, C. H., Caselli, R. J., Houlden, H., et al. (2011) · Movement Disorders · doi:10.1002/mds.23776 · Cited by 40
Young‐onset multiple system atrophy: Clinical and pathological features
Batla, A., Pablo‐Fernández, E. D., Erro, R., Reich, M. M., Buonaura, G. C., Barbosa, P., Balint, B., Ling, H., Islam, S., Cortelli, P., et al. (2018) · Movement Disorders · doi:10.1002/mds.27450 · Cited by 40
Abdo, W. F., van de Warrenburg, B. P. C., Kremer, H., Bloem, B. R., & Verbeek, M. M. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.02.002 · Cited by 39
Current Concepts in the Treatment of Multiple System Atrophy
Perez‐Lloret, S., Flabeau, O., Fernagut, P., Traon, A. P., Rey, M. V., Foubert‐Samier, A., Tison, F., Rascol, O., & Meissner, W. G. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12145 · Cited by 39
Yoon, R. G., Kim, S. J., Kim, H. S., Choi, C. G., Kim, J. S., Oh, J. S., Chung, S. J., & Lee, C. S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.046 · Cited by 39
Vasta, R., Nicoletti, A. S. Q., Mostile, G., Dibilio, V., Sciacca, G., Contrafatto, D., Cicero, C. E., Raciti, L., Luca, A., & Zappia, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172145 · Cited by 36
White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study
Zanigni, S., Evangelisti, S., Testa, C. M., Manners, D. N., Buonaura, G. C., Guarino, M., Gabellini, A. S., Gramegna, L. L., Giannini, G., Sambati, L., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.03.001 · Cited by 36
Goebel, G., Seppi, K., Donnemiller, E., Warwitz, B., Wenning, G. K., Virgolini, I. J., Poewe, W. H., & Scherfler, C. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1681-0 · Cited by 35
Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism
Segovia, F., Górriz, J. M., Ramírez, J., Martínez-Murcia, F. J., Levin, J., Schuberth, M., Brendel, M., Rominger, A., Bötzel, K., Garraux, G., et al. (2017) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2017.00023 · Cited by 35
Available and future treatments for atypical parkinsonism. A systematic review
Moretti, D. V. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13068 · Cited by 35
SHC2 gene copy number in multiple system atrophy (MSA)
Ferguson, M. C., Garland, E. M., Hedges, L. K., Womack, B., Hamid, R., Phillips, J. A., Shibao, C. A., Raj, S. R., Biaggioni, I., & Robertson, D. (2013) · Clinical Autonomic Research · doi:10.1007/s10286-013-0216-8 · Cited by 33
Hellwig, S., Reinhard, M., Amtage, F., Guschlbauer, B., Buchert, R., Tüscher, O., Weiller, C., Niesen, W., & Meyer, P. T. (2014) · European Journal of Neurology · doi:10.1111/ene.12394 · Cited by 31
Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting
Walsh, R. R., Krismer, F., Galpern, W. R., Wenning, G. K., Low, P. A., Halliday, G. M., Koroshetz, W. J., Holton, J. L., Quinn, N. P., Rascol, O., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004798 · Cited by 30
The Value of GRE, ADC and Routine MRI in Distinguishing Parkinsonian Disorders
Wadia, P. M., Howard, P., Ribeirro, M. Q., Robblee, J. V., Asante, A., Mikulis, D. J., & Lang, A. E. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100014360 · Cited by 28
Roles of cardiac sympathetic neuroimaging in autonomic medicine
Goldstein, D. S., & Cheshire, W. P. (2018) · Clinical Autonomic Research · doi:10.1007/s10286-018-0547-6 · Cited by 28
Early distinction of Parkinson‐variant multiple system atrophy from Parkinson's disease
Fanciulli, A., Goebel, G., Lazzeri, G., Scherfler, C., Gizewski, E. R., Granata, R., Kiss, G., Strano, S., Colosimo, C., Pontieri, F. E., et al. (2019) · Movement Disorders · doi:10.1002/mds.27635 · Cited by 28
Octreotide in the Management of Orthostatic Hypotension in Multiple System Atrophy
Bordet, R., Benhadjali, J., Libersa, C., & Destée, A. (1994) · Clinical Neuropharmacology · doi:10.1097/00002826-199408000-00010 · Cited by 26
Challenge-Oriented Gait and Balance Training in Sporadic Olivopontocerebellar Atrophy: A Case Study
Landers, M. R., Adams, M., Acosta, K., & Fox, A. F. A. (2009) · Neurology Report · doi:10.1097/npt.0b013e3181b511f4 · Cited by 26
Symptomatic therapy of multiple system atrophy
Rohrer, G., Höglinger, G. U., & Levin, J. (2017) · Autonomic Neuroscience · doi:10.1016/j.autneu.2017.10.006 · Cited by 25
Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type
Vergnet, S., Hives, F., Foubert‐Samier, A., Payoux, P., Fernandez, P., Meyer, M., Dupouy, J., Brefel‐Courbon, C., Ory‐Magne, F., Rascol, O., et al. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.006 · Cited by 24
Olfaction in pathologically proven patients with multiple system atrophy
Glass, P. G., Lees, A. J., Mathias, C. J., Mason, L., Best, C., Williams, D. R., Katzenschlager, R., & Silveira‐Moriyama, L. (2011) · Movement Disorders · doi:10.1002/mds.23972 · Cited by 23
Kuzdas-Wood, D., Irschick, R., Theurl, M., Malsch, P., Mair, N., Mantinger, C., Wanschitz, J., Klimaschewski, L. P., Poewe, W. H., Stefanova, N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136575 · Cited by 23
Silveira‐Moriyama, L., Gonzalez, A. M. D., O’Sullivan, S. S., Williams, D. R., Massey, L. A., Parkkinen, L., Ahmed, Z., de Silva, R., Chacón, J., Révész, T., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.036 · Cited by 22
LRRK2 p.Ile1371Val Mutation in a Case with Neuropathologically Confirmed Multi-System Atrophy
Lee, K., Nguyen, K.-D. H., Sun, C., Liu, M., Zafar, F., Saetern, J., Flierl, A., Tetrud, J. W., Langston, J. W., Dickson, D. W., et al. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171237 · Cited by 22
Respondek, G., Levin, J., & Höglinger, G. U. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000581 · Cited by 22
Association Between Parkinsonism and Participation in Agriculture in Korea
Cho, J., Jeon, B. S., Jeong, D., Choi, Y., Lee, J., Lee, H.-S., & Hong, S. (2008) · Journal of Clinical Neurology · doi:10.3988/jcn.2008.4.1.23 · Cited by 20
Zhang, K., Liang, Z., Wang, C., Zhang, X., Yu, B., & Liu, X. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.08.007 · Cited by 19
Potential clinical utility of multiple system atrophy biomarkers
Jellinger, K. A. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1392239 · Cited by 18
Abnormal pain perception in patients with Multiple System Atrophy
Ory‐Magne, F., Pellaprat, J., Harroch, E., Galitzsky, M., Rousseau, V., Traon, A. P., Rascol, O., Gerdelat, A., & Brefel‐Courbon, C. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.12.001 · Cited by 14
Mari, S., Hara, M., Ebashi, M., Morita, A., Okada, K., Homma, T., Sugitani, M., Endo, K., Uchihara, T., & Kamei, S. (2017) · Neuropathology · doi:10.1111/neup.12381 · Cited by 13
Ocular features of multiple system atrophy
Garcia, M. D., Pulido, J. S., Coon, E. A., & Chen, J. J.-W. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.10.028 · Cited by 12
PET Molecular Imaging in Atypical Parkinsonism
Xu, Z., Arbizu, J., & Pavese, N. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.09.001 · Cited by 12
Lee, J. E., Song, S., Hong, J. Y., Sunwoo, M.-K., Park, H.-J., Sohn, Y. H., & Lee, P. H. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.12.002 · Cited by 10
SPECT Molecular Imaging in Atypical Parkinsonism
Brumberg, J., & Isaias, I. U. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.08.006 · Cited by 10
Topography of Dopamine Transporter Availability in the Cerebellar Variant of Multiple System Atrophy
Nocker, M., Seppi, K., Boesch, S., Donnemiller, E., Virgolini, I. J., Wenning, G. K., Poewe, W. H., & Scherfler, C. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12446 · Cited by 6
Imaging Markers of Disease Progression in Multiple System Atrophy
Heim, B., Krismer, F., Poewe, W. H., & Seppi, K. (2019) · Future Neurology · doi:10.2217/fnl-2018-0045 · Cited by 5
Neuropsychiatric Manifestations in Atypical Parkinsonian Syndromes
Stanković, I., & Wenning, G. K. (2014) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-09537-0_7 · Cited by 3
Cited by
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033118 · Cited by 1,124
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
Wenning, G. K., Stankovic, I., Vignatelli, L., Fanciulli, A., Calandra‐Buonaura, G., Seppi, K., Palma, J., Meissner, W. G., Krismer, F., Berg, D., et al. (2022) · Movement Disorders · doi:10.1002/mds.29005 · Cited by 833
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies
Peng, C., Gathagan, R. J., Covell, D. J., Medellin, C., Stieber, A., Robinson, J. L., Zhang, B., Pitkin, R. M., Olufemi, M. F., Luk, K. C., et al. (2018) · Nature · doi:10.1038/s41586-018-0104-4 · Cited by 605
Aoyama, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095010 · Cited by 336
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Metadata
- Venue
- International Review of Neurobiology
- Publisher
- Elsevier
- Published
- 2019
- Volume
- 149
- Pages
- 137-192
- ISSN
- 0074-7742 (ISSN-L)
- OpenAlex
- W3005718086
- Cited by
- 253
- References
- 261
- FWCI
- 101.20
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.